Liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 and 80, regardless of gender. 2. Patients with primary liver cancer, preoperative upper abdominal stage 3 CT scan. 3. Preoperative liver function Child grade A or B, prothrombin time (PT) less than 4 seconds of normal control. No hepatic encephalopathy or/and significant ascites. Renal function and cardiopulmonary function are basically normal. Hemoglobin >= 90 g/L, white blood cell count >= 3.0 x 10^9/L, neutrophil count >= 1.5 x 10^9/L, and platelet count >= 60 x 10^9/L. 4. Those who can understand the study and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who have received chemotherapy, biological therapy, or participated in clinical trials of other drugs or devices prior to enrollment. 2. Preoperative assessment without indication for surgical resection. 3. Who are expected to be unable to tolerate surgical treatment after preoperative assessment of liver function. 4. Persons with obvious contraindications such as hepatic, renal and cardiac insufficiency and those who, in the opinion of the investigator, should not participate in this trial for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy;reliabiliy; | — |
Secondary
| Measure | Time frame |
|---|---|
| predictive value; | — |
Countries
China
Contacts
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University